Abstract

Prion diseases are a group of fatal and debilitating neurodegenerative diseases affecting humans and animal species. The conversion of a non-pathogenic normal cellular protein (PrPc) into an abnormal infectious, protease-resistant, pathogenic form prion protein scrapie (PrPSc), is considered the etiology of these diseases. PrPSc accumulates in the affected individual’s brain in the form of extracellular plaques. The molecular pathways leading to neuronal cell death in prion diseases are still unclear. The free radical damage, oxidative stress and mitochondrial dysfunction play a key role in the pathogenesis of the various neurodegenerative disorders including prion diseases. The brain is very sensitive to changes in the redox status. It has been demonstrated that PrPc behaves as an antioxidant, while the neurotoxic prion peptide PrPSc increases hydrogen peroxide toxicity in the neuronal cultures leading to mitochondrial dysfunction and cell death. The nuclear factor erythroid 2-related factor 2 (NRF2) is an oxidative responsive pathway and a guardian of lifespan, which protect the cells from free radical stress-mediated cell death. The reduced glutathione, a major small molecule antioxidant present in all mammalian cells, and produced by several downstream target genes of NRF2, counterbalances the mitochondrial reactive oxygen species (ROS) production. In recent years, it has emerged that the ubiquitin-binding protein, p62-mediated induction of autophagy, is crucial for NRF2 activation and elimination of mitochondrial dysfunction and oxidative stress. The current review article, focuses on the role of NRF2 pathway in prion diseases to mitigate the disease progression.

Highlights

  • Transmissible spongiform encephalopathies (TSEs), termed prion diseases, are a group of rare and progressive neurodegenerative disorders affecting several mammalian species including humans

  • We propose that simultaneous selective targeting of p62 and nuclear factor erythroid 2-related factor 2 (NRF2) might prove beneficial to reduce prion-induced autophagic defects and oxidative stress on one hand while it can decrease the levels of prion protein scrapie (PrPSc) on the other hand, which is sure to further decrease the oxidative stress to enhance survival

  • Called as TSEs, are a unique group of terminally debilitating neurodegenerative disorders characterized by a long-term progressive deterioration leading to motor paralysis and complete disability in affected humans

Read more

Summary

INTRODUCTION

Transmissible spongiform encephalopathies (TSEs), termed prion diseases, are a group of rare and progressive neurodegenerative disorders affecting several mammalian species including humans. It has been documented that some of the electrophilic lipids, for example, the subset of prostaglandins known as cyclopentenone prostaglandin, 15-deoxy-∆12,14–prostaglandin J2 (that act as a study model to view the impact of lipid peroxidation products resulting from the reactions of ROS with the unsaturated fatty acids), are able to trigger the NRF2 pathway by modifying the thiol groups of the Keap domain (Levonen et al, 2004) Another critical pathway or signaling mechanism by which the modification of the various cysteines in Keap leads to the suppressed degradation of NRF2 is through the decreased affinity of Keap for the Cul protein (Gao et al, 2007; Eggler et al, 2009). This machinery could engage those signaling cascades that can take part in the GSK-3 regulation, such as the PI3K/Akt or WNT signaling cascades (Figure 1D)

OXIDATIVE STRESS IN PRION DISEASES
MITOCHONDRIAL DYSFUNCTION IN PRION DISEASES
Intended usage
Findings
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call